Ratiometric detection of propafenone hydrochloride with one-pot synthesized dual emissive carbon dots

被引:5
作者
Zhang, Yuecheng [1 ]
Zhang, Jie [1 ]
Sun, Lingbo [2 ]
Tian, Rui [1 ]
Ma, Hongyan [1 ]
机构
[1] Yanan Univ, Coll Chem & Chem Engn, Key Lab Analyt Technol & Detect Yanan, Yanan 716000, Shaanxi, Peoples R China
[2] Yanan Univ, Med Coll, Yanan 716000, Shaanxi, Peoples R China
关键词
Propafenone hydrochloride; Carbon dots; Ratiometric; Fluorescence; PHASE SYNTHESIS; QUANTUM DOTS; METABOLITES; PHARMACOKINETICS; GRAPHENE; PH;
D O I
10.1007/s11696-022-02489-2
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Propafenone hydrochloride (PPF) is an antiarrhythmic drug used for the treatment of heart diseases with complex pharmacokinetics and a strict requirement on dosage. Current analytical methods for PPF determination require expensive instruments or much time for sample pre-treatment. Thus, it is urgent to establish a simple and time-saving approach for PPF determination. In this work, the dual emissive carbon dots (DECDs) were synthesized through one-step solvothermal treatment with m-aminophenol and citric acid. Two separate fluorescence emission peaks at 340 nm and 420 nm of DECDs are observed under the excitation wavelength of 306 nm. In the presence of PPF, the fluorescence signal at 340 nm decreased, while the signal at 420 nm gradually increased. We interestingly found that the fluorescence signal ratio (F-420/F-340) linearly changed with the concentration of PPF. Therefore, a simple and time-saving ratiometric fluorescent approach for the determination of PPF was developed using DECDs as a probe, showing an excellent linear range from 900 to 100 mu M. The detection limit is calculated to be 88 nM. It is a simple and low-cost strategy for PPF detection. The content of PPF was successfully analyzed in commercial tablets and in complex biological samples with satisfactory recoveries (ranging from 97.1 to 103.3%), showing great potential for application in clinical research.
引用
收藏
页码:375 / 383
页数:9
相关论文
共 37 条
[1]   A rapid HPLC assay tor the simultaneous determination of propafenone and its major metabolites in human serum [J].
Afshar, M ;
Rouini, M .
ANALYTICAL SCIENCES, 2004, 20 (09) :1307-1311
[2]   Validated capillary electrophoresis assay for the simultaneous enantioselective determination of propafenone and its major metabolites in biological samples [J].
Afshar, Minoo ;
Thormann, Wolfgang .
ELECTROPHORESIS, 2006, 27 (08) :1517-1525
[3]   Recent advances in the modification of carbon-based quantum dots for biomedical applications [J].
Alaghmandfard, Amirhossein ;
Sedighi, Omid ;
Rezaei, Nima Tabatabaei ;
Abedini, Amir Abbas ;
Khachatourian, Adrine Malek ;
Toprak, Muhammet S. ;
Seifalian, Alexander .
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2021, 120
[4]   Highly sensitive UHPLC-MS/MS method for the simultaneous estimation of propafenone and its metabolites 5-hydroxypropafenone and N-depropylpropafenone on human dried blood spots technique and application to a pharmacokinetic study [J].
Andy, Adinarayana ;
Kallem, Raja Reddy ;
Mullangi, Ramesh ;
Andy, Divya ;
Rao, J. V. L. N. Seshagiri .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2017, 142 :328-336
[5]   Nitric Oxide Sensing through Azo-Dye Formation on Carbon Dots [J].
Bhattacharya, Sagarika ;
Sarkar, Rhitajit ;
Chakraborty, Biswarup ;
Porgador, Angel ;
Jelinek, Raz .
ACS SENSORS, 2017, 2 (08) :1215-1224
[6]   PROPAFENONE - A REAPPRAISAL OF ITS PHARMACOLOGY, PHARMACOKINETICS AND THERAPEUTIC USE IN CARDIAC-ARRHYTHMIAS [J].
BRYSON, HM ;
PALMER, KJ ;
LANGTRY, HD ;
FITTON, A .
DRUGS, 1993, 45 (01) :85-130
[7]   PROPAFENONE IN THE TREATMENT OF CARDIAC-ARRHYTHMIAS - A RISK-BENEFIT APPRAISAL [J].
CAPUCCI, A ;
BORIANI, G .
DRUG SAFETY, 1995, 12 (01) :55-72
[8]   Detection of Hg2+ by a Dual-Fluorescence Ratio Probe Constructed with Rare-Earth-Element-Doped Cadmium Telluride Quantum Dots and Fluorescent Carbon Dots [J].
Chu, Hongtao ;
Yao, Dong ;
Chen, Jiaqi ;
Yu, Miao ;
Su, Liqiang .
ACS OMEGA, 2021, 6 (16) :10735-10744
[9]   A new sensing platform based on NH2fMWCNTs for the determination of antiarrhythmic drug Propafenone in pharmaceutical dosage forms [J].
Farag, Amir S. ;
Bakirhan, Nurgul K. ;
Svancara, Ivan ;
Ozkan, Sibel A. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 174 :534-540
[10]  
FUNCKBRENTANO C, 1990, NEW ENGL J MED, V322, P518